Atovaquone/proguanil for malaria chemoprophylaxis - Could a difference in susceptibility during hepatic development explain the need to continue drug intake for 7 days post-exposure?

Travel Med Infect Dis. Jan-Feb 2020;33:101527. doi: 10.1016/j.tmaid.2019.101527. Epub 2019 Nov 21.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Atovaquone / therapeutic use
  • Chemoprevention
  • Drug Combinations
  • Humans
  • Malaria* / drug therapy
  • Malaria* / prevention & control
  • Proguanil* / therapeutic use

Substances

  • Drug Combinations
  • atovaquone, proguanil drug combination
  • Proguanil
  • Atovaquone